242 related articles for article (PubMed ID: 24943293)
21. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
22. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
[TBL] [Abstract][Full Text] [Related]
23. Optimized Surveillance Intervals Following Endoscopic Eradication of Dysplastic Barrett's Esophagus: An International Cohort Study.
Kahn A; Crook J; Heckman MG; Wieczorek MA; Sami S; Snyder D; Agarwal S; Santiago J; Fernandez-Sordo JO; Tan WK; Lansing R; Wang KK; Ragunath K; DiPietro M; Wolfsen H; Ramirez F; Fleischer D; Leggett CL; Iyer PG
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2763-2771.e3. PubMed ID: 35245702
[TBL] [Abstract][Full Text] [Related]
24. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus.
Bansal A; McGregor DH; Anand O; Singh M; Rao D; Cherian R; Wani SB; Rastogi A; Singh V; House J; Jones PG; Sharma P
Dis Esophagus; 2014; 27(8):751-6. PubMed ID: 24165297
[TBL] [Abstract][Full Text] [Related]
25. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
26. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
Reid BJ; Blount PL; Feng Z; Levine DS
Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
[TBL] [Abstract][Full Text] [Related]
27. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
28. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
[TBL] [Abstract][Full Text] [Related]
29. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
[TBL] [Abstract][Full Text] [Related]
30. [Barrett's esophagus carcinoma].
Messmann H
Praxis (Bern 1994); 2006 Jun; 95(25-26):1029-35. PubMed ID: 16836063
[TBL] [Abstract][Full Text] [Related]
31. [Endoscopic diagnosis of Barrett's adenocarcinoma].
Yoshio H; Takashi Y; Mitsuyo H; Nobuhiko Y; Tatsurou T; Kazuhiko S; Yoko H; Shigemasa I; Hisanaga M; Osamu H; Katsuyoshi S; Seishi U; Matsushita H; Masahiko T
Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):244-8. PubMed ID: 10379534
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus.
Weston AP; Krmpotich PT; Cherian R; Dixon A; Topalovski M
Dig Dis Sci; 1997 Mar; 42(3):597-602. PubMed ID: 9073145
[TBL] [Abstract][Full Text] [Related]
33. Impact of advanced endoscopic imaging on Barrett's esophagus in daily clinical practice.
Beg S; Mensa M; Fullard M; Finerty E; Richman P; Leahy A
Gastrointest Endosc; 2018 May; 87(5):1189-1194. PubMed ID: 28958906
[TBL] [Abstract][Full Text] [Related]
34. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.
Harrison R; Perry I; Haddadin W; McDonald S; Bryan R; Abrams K; Sampliner R; Talley NJ; Moayyedi P; Jankowski JA
Am J Gastroenterol; 2007 Jun; 102(6):1154-61. PubMed ID: 17433019
[TBL] [Abstract][Full Text] [Related]
35. Intestinal metaplasia in follow-up endoscopies among Asian patients with short-segment Barrett's esophagus: Regression, sampling error, and associated factors.
Lin KH; Liao JB; Chen YH; Wang HM; Sun WC; Kao SS; Tsai TJ; Tsay FW; Tsai WL; Lee CH; Chen WC; Yu HC
J Formos Med Assoc; 2024 Feb; 123(2):238-247. PubMed ID: 37586970
[TBL] [Abstract][Full Text] [Related]
36. Best Practices in Surveillance for Barrett's Esophagus.
Triggs JR; Falk GW
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):59-75. PubMed ID: 33213800
[TBL] [Abstract][Full Text] [Related]
37. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?
Inadomi JM; Saxena N
Dig Dis Sci; 2018 Aug; 63(8):2094-2104. PubMed ID: 29948571
[TBL] [Abstract][Full Text] [Related]
38. Improving cost-effectiveness of endoscopic surveillance for Barrett's esophagus by reducing low-value care: a review of economic evaluations.
Vissapragada R; Bulamu NB; Brumfitt C; Karnon J; Yazbeck R; Watson DI
Surg Endosc; 2021 Nov; 35(11):5905-5917. PubMed ID: 34312726
[TBL] [Abstract][Full Text] [Related]
39. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
Ormsby AH; Vaezi MF; Richter JE; Goldblum JR; Rice TW; Falk GW; Gramlich TL
Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
